Skip to main content
. 2010 Nov 15;13(1):152–158. doi: 10.1038/aja.2010.108

Table 1. Asian prevalence of ED.

Author(s), year published (Prins score) Country of study Population type Age of participants (years) Eligibility criteria Number (% respondents) Differences/non-responders
Masumori et al., 19996 (10) Japan All men in a fishing village 40–79 No prostate or bladder cancer or surgery, antiandrogen, CVA or neurogenic bladder 289 (46.8%); 42.3% analyzed NS
Kongkanand, 20007 (11) Thailand Region stratified RPS 40–70 NS 1250 NS
Nicolosi et al., 200312 (11) Brazil RPS 40–70 Householder Total number 2513 NS
  Italy       Brazil (92%)  
  Japan       Italy (72%)  
  Malaysia       Japan (51%)  
          Malaysia (16%)  
Nicolosi et al., 200413 (11) Northern Europe: Austria/Belgium/Germany/Sweden/United Kingdom RPS 40–80 Men and women householder 27 500 (19%); 13 618 men  
  Southern Europe: Italy/France/Israel/Spain          
  Non-European West: Australia/Canada/ New Zealand/South Africa/United States          
  Central/South American: Brazil/Mexico          
  Middle East: Algeria/Egypt/Morocco/Turkey          
  East Asia: China/Hong Kong (China)/Japan/Korea/Taiwan          
  Southeast Asia: Malaysia/Philippines/Singapore/Thailand          
Nicolosi et al., 2001–2002/20059 (11) Mainland China, Hong Kong (China), Taiwan, South Korea, Japan, Thailand, Malaysia, Indonesia, Singapore, Philippines RPS 40–80 Men/women urban residents 6700 (27%); 3350 men NS
Moreira et al., 2001–2002/200610 (14) Korea RPS 40–80 40–80 years 600 (32.5%) NS
Ahn et al., 2004/200711 (12) Korea Region stratified RPS 40–79 All men 1570 Similar (statistically significant) to population published in National Health and Nutrition Survey
Laumann et al., 2001–2002/200514 (14) World RPS 40–80 40–80 years 13 750 (19%) NS